Novo Nordisk Patient Assistance Program (2026)
Published 2026-07-01 · Updated 2026-07-08 · MetaDose Research
Free comparison
Compare GLP-1 providers & cash-pay options
See telehealth and pharmacy programs that may lower your monthly cost.
MetaDose may earn a fee through partner links. See our disclaimer.
Novo Nordisk's patient assistance program provides Ozempic and Wegovy at low or no cost for uninsured patients meeting income limits (typically ≤400% federal poverty level). Application requires prescriber and income documentation.
Who qualifies
- Uninsured or Medicare Part D gap (program-specific)
- Income at or below program threshold
- US residency
- Prescription from licensed provider
How to apply
Ask your prescriber to submit via NovoCare portal. Processing: 2–4 weeks. Meanwhile see cash pay options.
If you have insurance
GLP-1 savings cards — different from patient assistance. Affordability Audit models both paths.
GLP-1 cost by state
Frequently Asked Questions
Is patient assistance permanent?
Re-enrollment yearly; income reverified annually.
Related tools & pages
More GLP-1 guides
Ozempic vs Wegovy Cost Same semaglutide — why prices differ GLP-1 Savings Cards 2026 NovoCare, Lilly — $25 copay programs Mounjaro vs Zepbound Cost Tirzepatide pricing compared GLP-1 Medicare Coverage What Part D covers in 2026 Ozempic Cost Without Insurance Cash pay Ozempic price: list cost, coupons, compounded alternatives, and true monthly spend. Wegovy Cost Per Month Monthly Wegovy price with insurance, savings card, and cash pay — national averages.